Guardant Health, Inc. (GH)

Guardant Health Revenue

Guardant Health had revenue of $334.98M in the quarter ending June 30, 2026, with 44.33% growth. This brings the company's total for the last twelve months to $1.18B, up 42.74% year-over-year. In the year 2025, Guardant Health had annual revenue of $982.02M with 32.88% growth. That makes Guardant Health the 6,907th largest company in the world by revenue and 1,679th in the United States.

• Revenue (ttm): $1.18B
• Revenue Growth: +42.74%
• P/S Ratio: 20.28
• Revenue / Employee: $472,109
• Employees: 2,506
• Market Cap: 23.99B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Oncology 683.60M 69.6%
• Biopharma and Data 210.13M 21.4%
• Screening 79.73M 8.1%
• Licensing and Other 8.56M 0.9%

By Geography

Chart

• United States 923.28M 94.0%
• International 58.74M 6.0%

Fiscal year ended Dec 31, 2025 See the full Guardant Health breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	982.02M	243.01M	32.88%
Dec 31, 2024	739.02M	175.07M	31.04%
Dec 31, 2023	563.95M	114.41M	25.45%
Dec 31, 2022	449.54M	75.89M	20.31%
Dec 31, 2021	373.65M	86.92M	30.32%
Dec 31, 2020	286.73M	72.36M	33.75%
Dec 31, 2019	214.38M	123.74M	136.52%
Dec 31, 2018	90.64M	40.80M	81.85%
Dec 31, 2017	49.84M	24.59M	97.40%
Dec 31, 2016	25.25M	-	-

Data Source: Fiscal.ai Last updated: Jul 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error